Lv12
66 积分 2025-02-14 加入
Tracking-seq reveals the heterogeneity of off-target effects in CRISPR–Cas9-mediated genome editing
10小时前
已完结
Reproducibility: changing the policies and culture of cell line authentication
1天前
已完结
Plasma Protein Binding as an Optimizable Parameter for In Vivo Efficacy
19天前
已完结
An update on the importance of plasma protein binding in drug discovery and development
1个月前
已完结
Targeted protein relocalization via protein transport coupling
2个月前
已完结
The many faces of partial inhibition: Revealing imposters with graphical analysis
2个月前
已完结
A new parameter of growth inhibition for cell proliferation assays
2个月前
已完结
Cancer therapy with antibodies
2个月前
已完结
Na+/K+ ATPase Inhibitors in Cancer
3个月前
已完结
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial
4个月前
已完结
皖公网安备34019202002308
